Semaglutide, the active ingredient in Ozempic, and other drugs in the same class have revolutionized the treatment of obesity and type 2 diabetes.Now, a clinical trial suggests the medicines can ...

Type 1 and type 2 diabetes are driven by very different mechanisms. In type 2 , cells in the pancreas that make insulin become less sensitive to blood sugar and produce less insulin in response.

Semaglutide, the active ingredient in Ozempic, and other drugs in the same class have revolutionized the treatment of obesity and type 2 diabetes. Now, a clinical trial suggests the medicines can ...